SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (21683)5/6/1999 10:37:00 AM
From: DaiS  Read Replies (1) of 23519
 
Vlad,

Not too bad release, but I'm not totally happy because of possibility to interpret that muse second best. But in reality most men WILL try viagra first, never having possibility to try muse first, so the release is consistent with Leland's pragmatic approach of trying to exploit coat-tail effect.

Pity that the combo study could not be exploited in some way. I'm convinced that even smaller doses of sildenafil and alprostadil combined will be very effective. Nehra and the Mayo clinic are influential I think so perhaps the combo treatment will result in increase muse sales also.

DaiS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News